Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 148 results.
User Information
Export Records
  1. 1.   Transcription factor Tox2 is required for metabolic adaptation and tissue residency of ILC3 in the gut
  2. Das, Arundhoti; Martinez-Ruiz, Gustavo Ulises; Bouladoux, Nicolas; Stacy, Apollo; Moraly, Josquin; Vega-Sendino, Maria; Zhao, Yongge; Lavaert, Marieke; Ding, Yi; Morales-Sanchez, Abigail; Harly, Christelle; Seedhom, Mina O; Chari,Raj; Awasthi, Parirokh; Ikeuchi, Tomoko; Wang, Yueqiang; Zhu, Jinfang; Moutsopoulos, Niki M; Chen, WanJun; Yewdell, Jonathan W; Shapiro, Virginia Smith; Ruiz, Sergio; Taylor, Naomi; Belkaid, Yasmine; Bhandoola, Avinash
  3. Immunity. 2024, May 14; 57(5): 1019-1036.
  1. 2.   Systemic inflammatory Th1 cytokines during Trypanosoma cruzi infection disrupt the typical anatomical cell distribution and phenotypic/functional characteristics of various cell subsets within the thymus
  2. Viano, Estefania; Baez, Natalia S; Savid-Frontera, Constanza; Baigorrí, Eliana; Dinatale, Brenda; Pacini, Maria Florencia; Bulfoni Balbi, Camila; Gonzalez, Florencia Belén; Fozzatti, Laura; Lidón, Nicolas L; Young,Howard; Hodge, Deborah; Cerban, Fabio; Stempin, Cinthia; Pérez, Ana Rosa; Rodriguez Galán, Maria Cecilia
  3. Microbes and Infection. 2024, Apr 12; 105337.
  1. 3.   Tumor eradication by hetIL-15 locoregional therapy correlates with an induced intratumoral CD103intCD11b+ dendritic cell population
  2. Stellas, Dimitris; Karaliota,Sevasti; Stravokefalou, Vasiliki; Angel, Matthew; Nagy,Bethany; Goldfarbmuren,Kate; Bergamaschi, Cristina; Felber,Barbara; Pavlakis,George
  3. Cell Reports. 2023, May 12; 42(5): 112501.
  1. 4.   IL-4, IL-13 and IFN-gamma induced genes in highly purified human neutrophils
  2. Kummola, Laura; Salomaa, Tanja; Ortutay, Zsuzsanna; Savan, Ram; Young,Howard; Junttila, Ilkka S
  3. Cytokine. 2023, Feb 19; 164: 156159.
  1. 5.   Safety and Efficacy of Dupilumab for the Treatment of Hospitalized Patients With Moderate to Severe Coronavirus Disease 2019: A Phase 2a Trial
  2. Sasson, Jennifer; Donlan, Alexandra N; Ma, Jennie Z; Haughey, Heather M; Coleman, Rachael; Nayak, Uma; Mathers, Amy J; Laverdure,Sylvain; Dewar,Robin; Jackson, Patrick E H; Heysell, Scott K; Sturek, Jeffrey M; Petri, William A
  3. Open Forum Infectious Diseases. 2022, Aug; 9(8): ofac343.
  1. 6.   Heterodimeric IL-15 (hetIL-15) reduces circulating tumor cells and metastasis formation improving chemotherapy and surgery in 4T1 mouse model of TNBC
  2. Stravokefalou, Vasiliki; Stellas, Dimitris; Karaliota,Sevasti; Nagy,Bethany; Valentin, Antonio; Bergamaschi, Cristina; Dimas, Konstantinos; Pavlakis,George
  3. Frontiers in Immunology. 2022, Jan 13; 13: 1014802.
  1. 7.   Reduced Antibodies and Innate Cytokine Changes in SARS-CoV-2 BNT162b2 mRNA Vaccinated Transplant Patients With Hematological Malignancies
  2. Bergamaschi, Cristina; Pagoni, Maria; Rosati,Margherita; Angel, Matthew; Tzannou, Ifigeneia; Vlachou, Margarita; Darmani, Ismini; Ullah,Amirah; Bear,Jenifer; Devasundaram,Santhi; Burns,Robert; Baltadakis, Ioannis; Gigantes, Stavros; Dimopoulos, Meletios-Athanasios; Pavlakis,George; Terpos, Evangelos; Felber,Barbara
  3. Frontiers in Immunology. 2022 13: 899972.
  1. 8.   Safety levels of systemic IL-12 induced by cDNA expression as a cancer therapeutic
  2. Savid-Frontera, Constanza; Viano, Maria E; Baez, Natalia S; Reynolds, Della; Matellon, Mariana; Young,Howard; Rodriguez-Galan, Maria C
  3. Immunotherapy. 2021, Nov 16;
  1. 9.   Systemic IL-15, IFN-?, and IP-10/CXCL10 signature associated with effective immune response to SARS-CoV-2 in BNT162b2 mRNA vaccine recipients
  2. Bergamaschi,Cristina; Terpos, Evangelos; Rosati,Margherita; Angel,Matthew; Bear,Jenifer; Stellas,Dimitris; Karaliota,Sevasti; Apostolakou, Filia; Bagratuni, Tina; Patseas, Dimitris; Gumeni, Sentiljana; Trougakos, Ioannis P; Dimopoulos, Meletios A; Felber,Barbara; Pavlakis,George
  3. Cell reports. 2021, Aug 10; 36(6): 109504.
  1. 10.   The Timing and Abundance of IL-2R beta (CD122) Expression Control Thymic iNKT Cell Generation and NKT1 Subset Differentiation
  2. Won, Hee Yeun; Kim, Hye Kyung; Crossman, Assiatu; Awasthi,Roackie; Gress, Ronald E.; Park, Jung-Hyun
  3. Frontiers in immunology. 2021, May 14; 12
  1. 11.   Inhibition of adjuvant-induced TAM receptors potentiates cancer vaccine immunogenicity and therapeutic efficacy
  2. Llopiz, Diana; Ruiz, Marta; Silva, Leyre; Reparaz, David; Aparicio, Belén; Egea, Josune; Lasarte, Juan J; Redin, Esther; Calvo, Alfonso; Angel,Matthew; Berzofsky, Jay A; Stroncek, David; Sarobe, Pablo
  3. Cancer Letters. 2021, Feb 28; 499: 279-289.
  1. 12.   Heterodimeric IL-15 in Cancer Immunotherapy
  2. Bergamaschi,Cristina; Stravokefalou,Vasiliki; Stellas,Dimitris; Karaliota,Sevasti; Felber,Barbara; Pavlakis,George
  3. Cancers. 2021, Feb 17; 13(4):
  1. 13.   Metabolic but not transcriptional regulation by PKM2 is important for Natural Killer cell responses
  2. Walls,Jessica; Subleski,Jeff; Palmieri,Erika; Gonzalez-Cotto,Marieli; Gardiner, Clair M; McVicar,Daniel; Finlay, David K
  3. eLife. 2020, Aug 19; 9: pii: e59166.
  1. 14.   Oral epithelial IL-22/STAT3 signaling licenses IL-17-mediated immunity to oral mucosal candidiasis
  2. Aggor, Felix E Y; Break, Timothy J; Trevejo-Nuñez, Giraldina; Whibley, Natasha; Coleman, Bianca M; Bailey, Rachel D; Kaplan, Daniel H; Naglik, Julian R; Shan, Wei; Shetty, Amol C; McCracken, Carrie; Durum,Scott; Biswas, Partha S; Bruno, Vincent M; Kolls, Jay K; Lionakis, Michail S; Gaffen, Sarah L
  3. Science immunology. 2020, Jun 05; 5(48): pii: eaba0570.
  1. 15.   Heterodimeric IL-15 delays tumor growth and promotes intratumoral CTL and dendritic cell accumulation by a cytokine network involving XCL1, IFN-?, CXCL9 and CXCL10
  2. Bergamaschi,Cristina; Pandit,Hrishikesh; Nagy,Bethany; Stellas,Dimitris; Jensen, Shawn M; Bear,Jenifer; Cam,Maggie; Valentin,Antonio; Fox, Bernard A; Felber,Barbara; Pavlakis,George
  3. Journal for immunotherapy of cancer. 2020, May; 8(1): e000599.
  1. 16.   rhIL-15 and anti-PD-L1 combination therapy expands a CXCR3+PD1-/low CD8 T cell subset in SIV-infected rhesus macaques
  2. Chen, Ping; Chen, Hui; Moussa, Maha; Cheng, Jie; Li, Tong; Qin, Jing; Lifson,Jeffrey; Sneller, Michael C; Krymskaya,Ludmila; Godin, Steven; Lane, H Clifford; Catalfamo, Marta
  3. The Journal of infectious diseases. 2020, Feb 15; 221(4): 523-533.
  1. 17.   IL15 by Continuous Intravenous Infusion to Adult Patients with Solid Tumors in a Phase I Trial Induced Dramatic NK-Cell Subset Expansion
  2. Conlon, Kevin C.; Potter, E. Lake; Pittaluga, Stefania; Lee, Chyi-Chia Richard; Miljkovic, Milos D.; Fleisher, Thomas A.; Dubois, Sigrid; Bryant, Bonita R.; Petrus, Michael; Perera, Liyanage P.; Hsu, Jennifer; Figg, William D.; Peer, Cody J.; Shih, Joanna H.; Yovandich,Jason; Creekmore,Stephen; Roederer, Mario; Waldmann, Thomas A.
  3. CLINICAL CANCER RESEARCH. 2019, Aug 15; 25(16): 4945-4954.
  1. 18.   IFN-gamma: A cytokine at the right time, is in the right place
  2. Burke,Daniel; Young,Howard
  3. Seminars in immunology. 2019, JUN; 43(Special Issue: SI):
  1. 19.   Molecular mechanisms of heparin-induced modulation of human interleukin 12 bioactivity
  2. Nguyen, Khue G.; Gillam, Francis B.; Hopkins, Jared J.; Jayanthi, Srinivas; Gundampati, Ravi Kumar; Su, Guowei; Bear,Jenifer; Pilkington, Guy R.; Jalah, Rashmi; Felber,Barbara; Liu, Jian; Thallapuranam, Suresh Kumar; Zaharoff, David A.
  3. JOURNAL OF BIOLOGICAL CHEMISTRY. 2019, Mar 22; 294(12): 4412-4424.
  1. 20.   Commensal-specific T cell plasticity promotes rapid tissue adaptation to injury
  2. Harrison, Oliver J.; Linehan, Jonathan L.; Shih, Han-Yu; Bouladoux, Nicolas; Han, Seong-Ji; Smelkinson, Margery; Sen, Shurjo; Byrd, Allyson L.; Enamorado, Michel; Yao, Chen; Tamoutounour, Samira; Van Laethem, Francois; Hurabielle, Charlotte; Collins, Nicholas; Paun, Andrea; Salcedo, Rosalba; O'Shea, John J.; Belkaid, Yasmine
  3. Science (New York, N.Y.). 2019, Jan 4; 363(6422): 43-+.
  1. 21.   IL-15/IL-15R alpha/CD80-expressing AML cell vaccines eradicate minimal residual disease in leukemic mice
  2. Shi, Yimin; Dincheva-Vogel, Lillie; Ayemoba, Charles E.; Fung, Jeffrey P.; Bergamaschi, Cristina; Pavlakis, George; Farzaneh, Farzin; Gaensler, Karin M. L.
  3. BLOOD ADVANCES. 2018, NOV 27; 2(22): 3177-3192.
  1. 22.   Optimized administration of hetIL-15 expands lymphocytes and minimizes toxicity in rhesus macaques
  2. Bergamaschi, Cristina; Watson, Dennis; Valentin, Antonio; Bear, Jenifer; Peer, Cody J; Figg, William D; Felber, Barbara; Pavlakis, George
  3. Cytokine. 2018, Aug; 108: 213-224.
  1. 23.   Cooperative Domain Formation by Homologous Motifs in HOIL-1L and SHARPIN Plays A Crucial Role in LUBAC Stabilization
  2. Fujita, Hiroaki; Tokunaga, Akira; Shimizu, Satoshi; Whiting, Amanda L; Aguilar Alonso, Francisco; Takagi, Kenji; Walinda, Erik; Sasaki, Yoshiteru; Shimokawa, Taketo; Mizushima, Tsunehiro; Ohki, Izuru; Ariyoshi, Mariko; Tochio, Hidehito; Bernal, Federico; Shirakawa, Masahiro; Iwai, Kazuhiro
  3. Cell Reports. 2018, Apr 24; 23(4): 1192-1204.
  1. 24.   Pharmacologic or Genetic Targeting of Glutamine Synthetase Skews Macrophages toward an M1-like Phenotype and Inhibits Tumor Metastasis
  2. Palmieri, Erika; Menga, Alessio; Martín-Pérez, Rosa; Quinto, Annamaria; Riera-Domingo, Carla; De Tullio, Giacoma; Hooper, Douglas C; Lamers, Wouter H; Ghesquière, Bart; McVicar, Daniel; Guarini, Attilio; Mazzone, Massimiliano; Castegna, Alessandra
  3. Cell Reports. 2017, Aug 15; 20(7): 1654-1666.
  1. 25.   Th1 Differentiation Drives the Accumulation of Intravascular, Non-protective CD4 T Cells during Tuberculosis.
  2. Sallin, Michelle A; Sakai, Shunsuke; Kauffman, Keith D; Young, Howard; Zhu, Jinfang; Barber, Daniel L
  3. Cell reports. 2017, Mar 28; 18(13): 3091-3104.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel